References

  1. Perucca E, Covanis A, Dua T. Commentary: epilepsy is a global problem. Epilepsia. 2014; 55(9):1326-1328. PubMed | Google Scholar

  2. Chin JH. Epilepsy treatment in sub-Saharan Africa: closing the gap. Afr Heal Sci. 2012; 12(2):186 -192. PubMed | Google Scholar

  3. Hunter E, Rogathi J, Chigudu S, Jusabani A, Jackson M, McNally R, Gray W, Whittaker RG, Iqbal A, Birchall D, Aris E, Walker R. Prevalence of active epilepsy in rural Tanzania: a large community-based survey in an adult population. Seizure. 2012; 21(9): 691-698. PubMed | Google Scholar

  4. Almu Sh, Tadesse Z, Cooper P, Hackett R. The prevalence of epilepsy in the Zay Society, Ethiopia-An area of high prevalence. Seizure. 2006;15(3): 211-213. PubMed | Google Scholar

  5. World Health Organization. Atlas: epilepsy care in the world. WHO, Geneva; 200 (at:http://www.who.int/mental_health/neurology/neurogy_atlas_lr.pdf) accessed on April 19, 2016. Google Scholar

  6. Mebrouk Y, Chettati M, Kissani N. L'épilepsie au Maroc, réalités et perspectives. NAMEEJ. 2012 ; 1(2) : 5-9. PubMed | Google Scholar

  7. Podell M. Antiepileptic Drug Therapy and Monitoring. Topics in Compan An Med. 2013; 28(2): 59-66. PubMed | Google Scholar

  8. Sirmagul B, Atli O, Ilgin S. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: A retrospective study. Human and Experimental Toxicology. 2012;31(10): 971-980. PubMed | Google Scholar

  9. Modi AC, Rausch JR, Glauser TA. Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy. JAMA. 2011 April 27;305(16):1669-1676. PubMed | Google Scholar

  10. Brandt C, Baumann P, Eckermann G, Hiemke C, May TW, Rambeck B, Pohlmann-Eden B. Therapeutic drug monitoring in Epileptologie and Psychiatrie. Nervenarzt. 2008;79(2):167-174. PubMed | Google Scholar

  11. Patsalos PhN, Berry DJ, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SJ, Leppik IE, Tomson T, Perucca E. Antiepileptic drugs'best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49(7):1239-1276. PubMed | Google Scholar

  12. Tomson T, Johannessen SI. Therapeutic monitoring of the new antiepileptic drugs. Eur J Clin Pharmacol. 2000; 55(10): 697-705. PubMed | Google Scholar

  13. Eadie MJ. Therapeutic drug monitoring - antiepileptic drugs. Br J Clin Pharmacol. 1998; 46(3):185-193. PubMed | Google Scholar

  14. Matar K M, Nicholls PJ, Tekle AB, Saleh A, Al-Hassan M. Liquid Chromatographic Determination of Six Antiepileptic Drugs and Two Metabolites in Microsamples of Human Plasma. Ther Drug Monit. October 1999;21(5): 559. PubMed | Google Scholar

  15. Aït Moussa L, Khassouani CE, Soulaymani R. Therapeutic isoniazid monitoring using a simple high-performance liquid chromatographic method with ultraviolet detection. J Chromatogr B. 2002;766(1):181-187. PubMed | Google Scholar

  16. Mandrioli R, Albani F, Casamenti G, Sabbioni C, Raggi MA. Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients. Journal of Chromatography B. 2001; 762 (2): 109-116. PubMed | Google Scholar

  17. Dordevic S, Kilibarda V, Stojanovic T. Determination of carbamazepine in serum and saliva samples by high performance liquid chromatography with ultraviolet detection. Vojnosanit Pregl. 2009;66(5):347-352. PubMed | Google Scholar

  18. Rahman F, Ahmed Abdelrahim HE, Mohamed Ibrahim MI. A survey of therapeutic drug monitoring services in Malaysia. Saudi Pharmaceutical Journal. 2013; 21(1): 19-24. PubMed | Google Scholar

  19. Dahiya K, Bansal P, Ghalaut VS, Dhankhar R, Ghalaut PS. Therapeutic drug monitoring for antiepileptic drugs using HPLC: an experience at a tertiary care hospital in India. Neurology Asia. 2010; 15(3): 233-237. PubMed | Google Scholar

  20. Fortuna A, Sousa J, Alves G, Falcao A, Soares-da-Silva P. Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma. Anal Bioanal Chem. 2010; 397(4):1605-1615. PubMed | Google Scholar

  21. Shibata M, Hashi S, Nakanishi H, Masuda S, Katsura T, Yano I. Detection of 22 antiepileptic drugs by ultraperformance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring. Biomed Chromatogr. 2012; 26(12):1519-1528. PubMed | Google Scholar

  22. Kissani N. Situation de l'épilepsie dans la région Nord Afrique et Moyen orient et Printemps Arabe. NAMEEJ. 2012;1(1):5-9. PubMed | Google Scholar

  23. Mebrouk Y, Chettati M, Kissani N. L'épilepsie au Maroc, réalités et perspectives. NAMEEJ. 2012;1(2):5-9. PubMed | Google Scholar

  24. Louhab N, Jafoui M, Stoti N, Kissani N. Prospective evaluation of traditional practices for epileptic patients of Marrakech. Epilepsia. 2005; 46(Suppl 6):356. PubMed | Google Scholar

  25. Belfkih R, Souirti Z, Belahsen F, Messouak O. L'épilepsie dans la région de Fès-Boulmane, Suivi prospectif d'une cohorte de 60 patients. NAMEEJ. 2012;1(4):19-22. PubMed | Google Scholar

  26. Mathew BS, Fleming DH, Thomas M, Prabha R, Saravanakumar K. An initial experience with therapeutic drug monitoring of levetiracetam as reported from a pediatric clinical setting in India. Neurology India. 2012;60(2):146-149. PubMed | Google Scholar

  27. Perucca E, Berlowitz D, Birnbaum A, Cloyd JC, Garrard J, Hanlon JT, Levy RH, Pugh MJ. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Research. 2006; 68S: S49-63. PubMed | Google Scholar

  28. Bassili A, Omar T, Zaki A, Abdel-fattah M, Tognoni G. Pattern of diagnostic and therapeutic care of childhood epilepsy in Alexandria, Egypt. International Journal for Quality in Health Care. 2002; 14(4):277-284. PubMed | Google Scholar

  29. Soldin OP, Soldin SJ. Review: therapeutic drug monitoring in pediatrics. Ther Drug Monit. 2002; 24(1):1-8. PubMed | Google Scholar

  30. Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E. Serum Carbamazepine Concentrations in Elderly Patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. Epilepsia. 2003; 44(7): 923-929. PubMed | Google Scholar

  31. Battino D, Croci D, Rossini A, Messina S, Mamoli D, Perucca E. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data. Clin Pharmacokinet. 2005;44(4):407-416. PubMed | Google Scholar

  32. Patsalos PhN, Berry DJ, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SJ, Leppik IE, Tomson T, Perucca E. Antiepileptic drugs'best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008; 49(7): 1239-1276. PubMed | Google Scholar

  33. EL Desoky ES, Sabarinath SN, Hamdi MM, Bewernitz M, Derendorf H. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. Journal of Clinical Pharmacy and Therapeutics. 2012;37(3): 352-355. PubMed | Google Scholar

  34. Milovanovic JR, Jankovic SM. Population pharmacokinetics of lamotrigine in patients with epilepsy. International Journal of Clinical Pharmacology and Therapeutics. 2009; 47(12):752-760. PubMed | Google Scholar

  35. Koristkova B, Grundmann M, Brozmanova H. Differences between prescribed daily doses and defined daily doses of antiepileptics-therapeutic drug monitoring as a marker of the quality of the treatment. International Journal of Clinical Pharmacology and Therapeutics. 2006;44(9):438-442. PubMed | Google Scholar

  36. Perucca E. Current Trends in Antiepileptic Drug Therapy. Epilepsia. 2003;44(S4):41-47. PubMed | Google Scholar

  37. Eadie MJ. Therapeutic drug monitoring ± antiepileptic drugs. Br J Clin Pharmacol. 2001;52(suppl 1):S11-20. PubMed | Google Scholar

  38. Sirmagul B, Atli O, Ilgin S. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study. Human and Experimental Toxicology. 2012;31(10):971-980. PubMed | Google Scholar

  39. Landmark CJ, Johannessen SI, Tomson T. Host factors affecting antiepileptic drug delivery-Pharmacokinetic variability. Advanced Drug Delivery Reviews. 2012;64(10):896-910. PubMed | Google Scholar

  40. Atl'O, Ilgin S, Sirmagul B. The effect of polytherapy on serum concentrations of traditional antiepileptics: a retrospective study. Toxicology Letters. 2011;205S:S160-179. PubMed | Google Scholar

  41. Patsalos PhN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurology. 2003;2(6):347-356. PubMed | Google Scholar

  42. Fukuoka N, Tsukamoto T, Uno J, Kimura M, Morita Sh. Effects of concomitant antiepileptic drugs on serum carbamazepine concentration in epileptic patients: quantitative analysis based on extracellular water volume as a transforming factor. Yakugaku Zasshi. 2003; 123(1):35-42. PubMed | Google Scholar

  43. Specht U, Elsner H, May TW, Schimichowski B, Thorbecke R. Postictal serum levels of antiepileptic drugs for detection of noncompliance. Epilepsy Behav. 2003;4(5):487-495. PubMed | Google Scholar

  44. Shakya G, Malla S, Shakya KN, Shrestha R. Therapeutic Drug Monitoring of Antiepileptic Drugs. J Nepal Med Assoc. 2008; 47(171):94-97. PubMed | Google Scholar

  45. Langan Y, Sander JWAS. Sudden unexpected death in patients with epilepsy definition, epidemiology and therapeutic implications. CNS Drugs. 2000;13(5):337-350. PubMed | Google Scholar